Prof. Dr. med. Laufs, Ulrich

Klinikdirektor, Klinik und Poliklinik für Kardiologie, Universitätsklinikum Leipzig

Publikationen:

Impact On Antihypertensive Prescribing After The Dear Healthcare Professional Letter On Increased Risk Of Skin Cancer Related To Hydrochlorothiazide

Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide population-based study

Declining rates of fixed-dose combination pills for hypertension in Germany from 2016 to 2023

Hidden sodium in effervescent-tablet dietary supplements and over-the- counter drugs: a comparative cross-sectional study

Trends in Ezetimibe Prescriptions as Monotherapy or Fixed-Dose Combination in Germany 2012–2021

Use of fixed‑dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia

Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

Utilization of drugs with reports on potential efficacy or harm on COVID-19 before, during, and after the first pandemic wave

Changes in utilization of antihypertensive drugs following angiotensin receptor blocker product recalls in Germany

Strategien zur Verbesserung der Einnahmetreue von Medikamenten.

Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients

Temporal synchrony between drug dispensings and adverse drug events? The example of statins & rhabdomyolysis and metamizole or clozapine & agranulocytosis

In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

Impact of angiotensin receptor blocker product recalls on antihypertensive prescribing in Germany

“Dear Doctor” Warning Letter (Rote-Hand-Brief) on Hydrochlorothiazide and Its Impact on Antihypertensive Prescription